| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | A |
| 7. Steady State | A |
| 8. Outlier Analysis | A |
| 9. Normality | A |
| 10. Variance Homogeneity | A |
| 11. ANOVA | A |
| 12. CI | A |
| 13. No of Results | A |
| 14. Concentrations | A |
| 15. Total Score | A1,2,3,4,5,6,7,8,9,10,11,12,13,14 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Plasma |
| Measurand | Fibroblast growth factor-23 |
| Unit | ng / L |
| Overall Analytical Principle Method | Chemiluminescence |
| Number of Subjects | 14 |
| Number of Subjects included in BV estimation | 14 |
| Ethinicity | Caucasian |
| Age Mean / Median | 32.0 |
| Age Min | 28.0 |
| Age Max | 40.0 |
| Age SD | |
| Number of Males | 7 |
| Number of Females | 7 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 6 |
| Study Duration Units | Week |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
| Interval Units | Week |
| Sampling Times | Start Time:
8:00
End Time: 10:00 |
| Number of Samples | 7 |
| Average Number of Samples Used for BV Estimation | 7.0 |
| Average Number of Replicates | 2.0 |
| Estimates of CVi | 14.2 |
| Calculated Confidence Intervals of CVi | Lower: 12.27, Upper: 16.81 |
| Estimates of CVg | 13.4 |
| Calculated Confidence Intervals of CVg | Lower: 9.02, Upper: 22.15 |
| Analytical CV | 3.7 |
| Calculated Confidence Intervals of Analytical CV | Lower: 3.25, Upper: 4.30 |
| Measurand Mean | 61.2 |
| Measurand Min | 56.0 |
| Measurand Max | 66.4 |
| Measurand SD |